DURHAM, N.C., November 10, 2016 — Researchers developing treatments for neurodegenerative disorders face some of the biggest hurdles in planning and conducting clinical drug trials. Get advice on navigating this difficult terrain by attending a Premier Research webinar on Tuesday, November 15.
Neurodegenerative Disease Research: Steps to a Successful Clinical Trial will describe a complex field of study in which diagnoses are often complicated by-delayed onset of symptoms, and where selection bias often besets trials that skew disproportionately young, male, and Caucasian.
Our presenters will talk about optimizing study design, recruitment, event adjudication, and biomarker use, and will address the vital role of reliable diagnostics and accurate, meaningful phenotypic descriptions and evaluation outcomes in generating high-quality data. Other topics will include enrolling the right patients and engaging the best investigators and staff to minimize rater variability and comply with often complex protocol requirements.
The hour-long session begin at 11am EST / 4pm GMT / 5pm CET. Register now for this wide-ranging examination of strategies that can help ensure clinical trial success.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.